Prescription drug · ANDA
Aurovela Fe 1/20 NDC 65862-940
norethindrone acetate and ethinyl estradiol and ferrous fumarate · Kit · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65862-940-58 | 6586209405865862094058 | 5 POUCH in 1 CARTON (65862-940-58) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACKMarketed from Jun 16, 2017 | |
| 65862-940-88 | 6586209408865862094088 | 3 POUCH in 1 CARTON (65862-940-88) / 1 BLISTER PACK in 1 POUCH (65862-940-87) / 1 KIT in 1 BLISTER PACKMarketed from Jun 16, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aurovela Fe 1/20
- Generic name (nonproprietary)
- norethindrone acetate and ethinyl estradiol and ferrous fumarate
- Dosage form
- Kit
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 65862
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207505
- Marketing start
- Listing expires
- Identifiers
- Product ID 65862-940_2fb192cb-1d17-41ce-8fbb-04f188f6079bSPL ID 2fb192cb-1d17-41ce-8fbb-04f188f6079bSPL set ID 83513d13-5352-4d86-9dfd-fd1e456087c0RxCUI 259176, 1358762, 1358763, 1926946
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N465862094058followed by a unit qualifier and the quantityPackage 65862-0940-58. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Aurovela Fe 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE 1 LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD % of Women Experiencing an Unintended Pregnancy in the First Year o…
Excerpt only. Read the full label for complete information.
About NDC 65862-940
- What is NDC 65862-940?
- 65862-940 is the product NDC for Aurovela Fe 1/20 kit, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Aurovela Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate).
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Aurovela Fe 1/20?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 207505
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tarina Fe 1/20 EQnorethindrone acetate and ethinyl estradiol and ferrous fumarate | — | Kit | Afaxys Pharma, LLC | 50102-228 |